|Articles|January 17, 2014
BioClinica, CCBR-SYNARC To Merge
BioClinica and CCBR-SYNARC have signed an agreement to merge their companies
Advertisement
BioClinica and CCBR-SYNARC have signed an agreement to merge their companies, with the combined company offering four highly specialized services to the clinical trials industry. Those services include medical imaging services across multiple therapeutic areas; worldwide network of research centers and sites; consulting services and cardiac safety monitoring services.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
2
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
3
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
4
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
5